Should low‑dose aspirin (acetylsalicylic acid) be continued in a patient with a 70% lesion of the left anterior descending (LAD) artery until the day of surgery?

Should Aspirin (Ecosprin) Be Continued Until Surgery in a Patient with 70% LAD Lesion?

Yes, aspirin should be continued until the day of surgery in a patient with significant coronary artery disease (70% LAD lesion) who has not undergone prior PCI, as the cardiac risk reduction outweighs the bleeding risk in most noncardiac surgical procedures. 1

Guideline-Based Recommendation

The 2024 AHA/ACC guidelines provide clear direction for this clinical scenario:

• In patients with CAD without prior PCI undergoing elective noncardiac surgery, it may be reasonable to continue aspirin (75-100 mg) when the risk of cardiac events outweighs the risk of bleeding. 1

• The recommendation is even stronger (Class I) for patients with prior PCI, where aspirin continuation is explicitly recommended to reduce cardiac events. 1

• Your patient with a 70% LAD lesion represents significant coronary disease with high thrombotic risk, making aspirin continuation the safer strategy in most surgical contexts. 1

Key Considerations for Decision-Making

When to Continue Aspirin:

• Most noncardiac surgeries: Continue aspirin through the perioperative period 1
• High cardiac risk patients (like your patient with 70% LAD stenosis): The benefit of preventing MI/stroke typically exceeds bleeding risk 1, 2
• Low to moderate bleeding risk procedures: Aspirin continuation is generally safe 1

When to Consider Stopping Aspirin:

• High bleeding-risk surgeries only: Intracranial surgery, spinal surgery, or procedures where even minor bleeding could cause catastrophic outcomes 1
• If stopping is necessary: Discontinue ≤7 days (not 7-10 days) before surgery 1
• Resume within 24 hours postoperatively when hemostasis is adequate 1

Evidence Supporting Continuation

Cardiovascular Protection:

• Aspirin withdrawal precedes up to 10.2% of acute cardiovascular syndromes, with acute coronary events occurring an average of 8.5 days after discontinuation 3
• The time window of vulnerability is narrow - cardiovascular events cluster within 2 weeks of aspirin cessation 3
• Studies show reduced oxidative stress and inflammation when aspirin is continued until surgery 4

Bleeding Risk Reality:

• Aspirin increases bleeding complications by a factor of only 1.5 across various surgical procedures 3
• Importantly, aspirin does not increase the severity of bleeding in most procedures (exceptions: intracranial surgery, possibly transurethral prostatectomy) 3
• In neurosurgical procedures, continued aspirin use showed no significant increase in postoperative hemorrhage requiring reoperation (3.1% vs 3.0%, p=1.000) 5

Special Consideration: If This is CABG Surgery

If your patient is scheduled for coronary artery bypass grafting (CABG), the recommendation differs:

• Continue aspirin until surgery - this is actually beneficial for CABG specifically 1
• The 2022 CHEST guidelines note that in CABG patients, aspirin use within 5 days prior to surgery was associated with reduced mortality without increased reoperation risk 1
• Resume aspirin within 24 hours post-CABG 1

Clinical Algorithm

For your patient with 70% LAD lesion:

1. Identify the type of surgery planned:

   • Low/moderate bleeding risk → Continue aspirin 75-100 mg daily 1
   • High bleeding risk (intracranial, spinal) → Consider stopping ≤7 days preoperatively 1

2. If aspirin must be stopped:

   • Stop ≤7 days before surgery (not earlier) 1
   • Resume within 24 hours postoperatively when hemostasis permits 1

3. Document the decision with clear rationale balancing cardiac vs bleeding risk 1

Common Pitfalls to Avoid

• Do not stop aspirin 7-10 days preoperatively - newer evidence supports ≤7 days if stopping is necessary 1
• Do not assume all surgeries require aspirin cessation - most procedures are safer with continued aspirin in CAD patients 1, 3
• Do not delay resumption postoperatively - restart within 24 hours unless active bleeding 1
• Do not forget that aspirin withdrawal itself carries cardiovascular risk - the decision to stop must be deliberate and justified 3

The 2024 AHA/ACC guidelines represent the most current evidence-based approach, emphasizing that aspirin continuation is the default strategy for most patients with CAD undergoing noncardiac surgery, with selective interruption only for truly high bleeding-risk procedures. 1